Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$766K Sell
5,034
-14,968
-75% -$2.49M 0.08% 349
2026
Q1
$4.2M Buy
20,002
+18,753
+1,501% +$4.71M 0.54% 13
2025
Q4
$355K Buy
+1,249
New +$391K 0.08% 382
2025
Q3
Sell
-1,307
Closed -$411K 775
2025
Q2
$411K Buy
+1,307
New +$377K 0.13% 266
2025
Q1
Sell
-2,776
Closed -$725K 648
2024
Q4
$725K Buy
+2,776
New +$699K 0.33% 109
2023
Q1
Sell
-3,310
Closed -$974K 606
2022
Q4
$974K Buy
+3,310
New +$913K 0.68% 27

Other funds holding PODD

AXQ Capital's PODD Position: Q2 2026 in Review

AXQ Capital reduced its Insulet (PODD) stake by 75% in Q2 2026, selling an estimated $2.49M and leaving 5,034 shares worth $766K. The position accounts for 0.08% of the portfolio, ranked #349.

AXQ Capital first reported a position in PODD in Q4 2022 and has held it in 6 quarters since. The position peaked at $4.2M in Q1 2026. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • AXQ Capital held 5,034 shares of Insulet worth $766K as of Q2 2026.
  • AXQ Capital sold 14,968 Insulet shares in Q2 2026, an estimated $2.49M.
  • Insulet made up 0.08% of AXQ Capital's portfolio in Q2 2026, its #349 holding.
  • AXQ Capital first reported a position in Insulet in Q4 2022 and has held it in 6 quarters since.
  • AXQ Capital's Insulet position peaked at $4.2M in Q1 2026.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.